Immunovant (IMVT) Debt Ratio (2019 - 2023)

Immunovant's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.0 for Q1 2023.

• Quarterly Debt Ratio rose 160.02% year-over-year to 0.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 0.0 (up 160.02% YoY) and the FY2023 annual result came in at 0.0, up 160.02% from the prior year.
• Debt Ratio was 0.0 for Q1 2023 at Immunovant, up from 0.0 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.04 in Q2 2019 and bottomed at 0.0 in Q3 2020.
• A 4-year average of 0.01 and a median of 0.0 in 2019 frame the typical range for Debt Ratio.
• Peak annual rise in Debt Ratio reached 595.27% in 2020, while the deepest fall reached 98.61% in 2020.
• Immunovant's Debt Ratio stood at 0.02 in 2019, then slumped by 98.81% to 0.0 in 2020, then increased by 12.35% to 0.0 in 2022, then soared by 160.02% to 0.0 in 2023.
• Business Quant data shows IMVT's Debt Ratio at 0.0 in Q1 2023, 0.0 in Q1 2022, and 0.0 in Q3 2020.